Back to Search

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

Rockville, Maryland, 20854
Wilmington, North Carolina, 28403
Cincinnati, Ohio, 45219
Glendale, Ohio, 45246
Pembroke Pines, Florida, 33024
Search ended 06/14/2022

The study comprises 2 parts: Phase 1/2 and Phase 2 Northern Hemisphere (NH). The primary objective of Phase 1/2 is to evaluate the safety and reactogenicity of 3 dose levels of mRNA-1010 vaccine administered as a single dose. The primary objective of Phase 2 NH is to evaluate the humoral immunogenicity of mRNA-1010 vaccine relative to that of an active comparator against vaccine-matched influenza A and B strains.

Eligibility

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, learn about Clinical

Ages Eligible for Study Min Age: 18 years - Max Age: N/A
Sexes Eligible for Study All
Accepts Healthy Volunteers Yes

Visit ClinicalTrials.Gov for more information
Support nonprofit organizations through participating in clinical trials at no cost to you
You may also be interested in
Hollywood, Florida and more
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 18- to 30-Year-Old Healthy Adults
Epstein-Barr Virus Infection Read more
Palo Alto, California and more
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Solid Tumor, Adult and more Read more
Pelham, Alabama and more
A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age
Cytomegalovirus Infection Read more